The draft report “Controversies in the Management of Patients with Type 2 Diabetes” and related voting questions are now posted for public comment. This report will be the subject of deliberation and vote at the next public meeting of CEPAC on Wednesday, October 29, 2014 in Providence, Rhode Island. This report aims to help members of CEPAC and the public understand the latest evidence on the relative effectiveness and value of various treatment options for individuals with type 2 diabetes, including new classes of oral and injectable medications, insulin, and medical devices.  The report includes a systematic review of published literature as well as budget impact analyses. It will be available for public comment until Wednesday, October 22, 2014.